| -1.43 / -4.06%|
The 4 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 42.50, with a high estimate of 60.00 and a low estimate of 36.00. The median estimate represents a +25.89% increase from the last price of 33.76.
The current consensus among 4 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.